Abstract

In our previous studies, we have identified that histamine (HA) is co-released with noradrenaline (NA) from the sympathetic nerve terminals and acts as a novel sympathetic neurotransmitter. However, the modulation of sympathetic HA release by sympathetic prejunctional receptors is still unknown. Therefore, in this study, we explored the modulation effect of α 2 adrenoceptors on sympathetic HA release and the interaction of α 2 adrenoceptors with HA H 3 receptors in vas deferens isolated from guinea pig. The selective α 2 adrenoceptor agonist brimonidine decreased the HA overflow in a concentration-dependent manner and abolished the contractile responses mediated by sympathetic HA release. Yohimbine competitively blocked the effect of brimonidine on HA release. Similarly, the HA H 3 receptor agonist R-(α)-methylhistamine also decreased HA release, and thioperamide blocked the effect of R-(α)-methylhistamine. When used singly, both yohimbine and thioperamide facilitated HA release. In addition, the inhibitory effect of brimonidine on HA release was stronger in the presence of thioperamide, while it was reduced when HA H 3 receptors were activated by R-(α)-methylhistamine. Our findings indicate for the first time that sympathetic HA release is negatively modulated both by prejunctional α 2 receptors and HA H 3 receptors and that these two prejunctional receptors interact with each other in modulating sympathetic HA release.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.